LFM-A13
| Overview | |
| Catalog # | bs-82019c-5mg |
| Product Name | LFM-A13 |
| Specifications | |
| Storage Buffer | White solid |
| Storage Condition | -20°C |
| Target | |
| Product Information | LFM-A13 is a selective inhibitor of Bruton’s tyrosine kinase (BTK) – IC50’s = 2.5 µM (recombinant BTK) and 17.2 µM (human BTK).1,2 It has also been shown to inhibit Polo-ilke kinase (PLK) – IC50 = 61 µM for human PLK3.3 It displayed no activity (concentrations up to 278 µM) at JAK1, JAK3, HCK, EGFRK and IRK2 or CDK1-3, CHK1, IKK, MAPK1, SAPK2a and ten tyrosine kinases3. |
| Description | CAS Number: 244240-24-2 Chemical Name: (2Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide Molecular weight: 360.00 Formula: C11H8Br2N2O2 Solubility: DMSO (15 mg/ml) Ethanol (15 mg/ml) Physical Properties: White solid Purity: 98% by TLC, NMR (Conforms) |